Results 11 to 20 of about 267,865 (313)
Obesity and dyslipidemia [PDF]
Metabolism, 2019 Obesity, a pandemic of the modern world, is intimately associated with dyslipidemia, which is mainly driven by the effects of insulin resistance and pro-inflammatory adipokines. However, recent evidence suggests that obesity-induced dyslipidemia is not a unique pathophysiological entity, but rather has distinct characteristics depending on many ...
Vekić, Jelena +4 more
openaire +5 more sources
Indian Journal of Endocrinology and Metabolism, 2013 Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C).
C N Manjunath +3 more
doaj +3 more sources
Frontiers in Endocrinology, 2021 White adipose tissue (WAT) possesses the endocannabinoid system (ECS) machinery and produces the two major endocannabinoids (ECs), arachidonoylethanolamide (AEA) and 2-arachidonoylglycerol (2-AG).
Chloé Buch +10 more
doaj +1 more source
Identifying high-risk and actionable profiles for prevention in hypertensive patients with concurrent dyslipidemia: a population-based retrospective study [PDF]
BMC Cardiovascular DisordersBackground Hypertension and dyslipidemia are major global risk factors for cardiovascular diseases, with their prevalence increasing annually. In China, hypertension and dyslipidemia exhibit a “dual high” epidemic characteristic.
Yizhou Xu +4 more
doaj +2 more sources
Study of dyslipidemia in patients with Obstructive Sleep Apnea Syndrome in primary health care [PDF]
, 2021 Background. Obstructve Sleep Apnea Syndrome (OSAS) is associated with several morbidites. The most important ones are obesity, hypertension and diabetes mellitus. A clear relatonship of OSAS and dyslipidemia is yet to be demonstrated. Objectves.
Santiago, Luiz Miguel de Mendonça Soares +10 more
core +1 more source
Journal of Translational Medicine, 2020 Background Elevated lipoprotein(a) [Lp(a)] and fibrinogen (Fib) are both associated with coronary artery disease (CAD). The atherogenicity of Lp(a) can be partly due to the potentially antifibrinolytic categories. We hypothesize that patients with higher
Yan Zhang +15 more
doaj +1 more source
Frontiers in Nephrology, 2023 ObjectiveThis study assessed the efficacy of INV-202, a novel peripherally restricted cannabinoid type-1 receptor (CB1R) inverse agonist, in a streptozotocin-induced type-1 diabetes nephropathy mouse model.MethodsDiabetes was induced in 8-week-old C57BL6/
Laetitia Jacquot +12 more
doaj +1 more source
sRAGE and early signs of cardiac target organ damage in mild hypertensives
Cardiovascular Diabetology, 2019 Background Soluble Receptor for Advanced Glycation End Products (sRAGE) may be considered a marker inversely related to inflammation and its participation has been established in patients with advanced atherosclerotic vascular diseases.
Andrea Maria Maresca +12 more
doaj +1 more source
OBESITY AND DYSLIPIDEMIA IN CHILDREN WITH CHRONIC HEPATITIS [PDF]
Romanian Journal of Pediatrics, 2016 Chronic hepatitis association with various types of dyslipidemia is a reality not only for the obese pediatric patient, in which we expect to find hypercholesterolemia and / or hypertriglyceridemias, but also for normal weight children with hepatitis ...
Alice N. Azoicai +7 more
doaj +1 more source
Prevalence and types of persistent dyslipidemia in patients treated with statins [PDF]
, 2013 Aim To determine the prevalence and types of persistent dyslipidemia in patients treated with different statins to reduce cardiovascular disease (CVD) risk, as well as to determine the proportion of high risk patients who did not reach the lipid ...
Željko Reiner +3 more
core +1 more source